Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory

  • STATUS
    Recruiting
  • day left to enroll
    1
  • participants needed
    100
  • sponsor
    Kazakh Medical University of Continuing Education
Updated on 22 August 2021
cancer
anxiety
depressed mood

Summary

Depression and anxiety in patients with breast cancer are serious comorbidities that affect the quality of life for patients and their survival rates as they have poorer health outcomes. This validation study is a part of the study on the prevalence of depression and anxiety among breast cancer patients. This study aims to investigate the validity of the Kazakh and Russian versions of the Beck Depression Inventory (BDI-II) and Beck Anxiety Inventory (BAI) among breast cancer patients in Almaty, Kazakhstan.

Details
Condition Endogenous depression, Depression, Breast Cancer, ANXIETY NEUROSIS, Anxiety, Breast Cancer Diagnosis, Depressed, Anxiety Symptoms, Anxiety Disorders, breast carcinoma, depressive disorder, cancer, breast, anxiety disorder, depressed mood, miserable, depressive disorders, anxious
Treatment Beck Anxiety Inventory, Beck Depression Inventory-21 (diagnostic survey), Interview using The Diagnostic and Statistical Manual of Mental Disorders-V (DSM - V)
Clinical Study IdentifierNCT04630327
SponsorKazakh Medical University of Continuing Education
Last Modified on22 August 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

adult female patients between 18 to 65 years of age with a primary diagnosis of breast cancer
Russian or Kazakh language fluency
consent to participate

Exclusion Criteria

history of diagnosed depression or anxiety
current use of antidepressants
referral to palliative care
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note